ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

December 31, 2004

Walter Reed Oncologic Pharmacy Residency Program Has Openings

November 25, 1988

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994

In Brief: NCCS Honors 14 Who Make A Difference; Lasker Awards Presented To Seven Scientists

October 2, 1998

In Brief: CT Scanning Of The Brain Subject Of Consensus Development Conference; CCI Plans Congress Events

July 10, 1981

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992